China furthers cancer diagnostics chip R&D
This article was originally published in Clinica
China is building its cancer diagnostics research using gene chip technology with the establishment of its first tumour gene chip research centre.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.